Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum

Pfizer Issued Warning Letter for Italian Manufacturing Plant

Company is notified of GMP violations at facility in Catania, Italy.
Apr 11, 2013

Company is notified of GMP violations at facility in Catania, Italy.

Navigating the Global Manufacturing Supply Chain

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.
Apr 10, 2013

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.

Pfizer Voluntarily Recalls Levoxyl

Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.
Apr 8, 2013

Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.

Eli Lilly Considers Investment in US Insulin-Manufacturing Capacity

Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.
Apr 8, 2013

Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.

Indian Supreme Court Rejects Patent for Glivec by Novartis

Ruling has implications for intellectual property protection for innovator drugs in India.
Apr 3, 2013

Ruling has implications for intellectual property protection for innovator drugs in India.

GlaxoSmithKline Tops Industry Rankings for Access to Medicines

The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.
Apr 3, 2013

The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.

The Plan by AstraZeneca CEO Pascal Soriot to Revitalize the Company

Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.
Apr 3, 2013

Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.

Advancing Flow Chemistry in API Manufacturing

Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations.
Apr 2, 2013

Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations.

Novartis Suffers Setback in Indian Patent Case for Glivec

Apr 2, 2013

Novartis loses an appeal in seeking patent protection in India for its anticancer drug.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
28%
Attracting a skilled workforce
26%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
33%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here